AU2015242374B2 - New use of N,N-bis-2-mercaptoethyl isophthalamide - Google Patents

New use of N,N-bis-2-mercaptoethyl isophthalamide Download PDF

Info

Publication number
AU2015242374B2
AU2015242374B2 AU2015242374A AU2015242374A AU2015242374B2 AU 2015242374 B2 AU2015242374 B2 AU 2015242374B2 AU 2015242374 A AU2015242374 A AU 2015242374A AU 2015242374 A AU2015242374 A AU 2015242374A AU 2015242374 B2 AU2015242374 B2 AU 2015242374B2
Authority
AU
Australia
Prior art keywords
nbmi
patient
treatment
symptom
ascorbate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015242374A
Other languages
English (en)
Other versions
AU2015242374A1 (en
Inventor
Boyd Eugene HALEY
Ragnar Axel Theodor KLINGBERG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emeramed Ltd
Original Assignee
Emeramed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50776843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2015242374(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emeramed Ltd filed Critical Emeramed Ltd
Publication of AU2015242374A1 publication Critical patent/AU2015242374A1/en
Application granted granted Critical
Publication of AU2015242374B2 publication Critical patent/AU2015242374B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2015242374A 2014-04-04 2015-03-31 New use of N,N-bis-2-mercaptoethyl isophthalamide Active AU2015242374B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1406115.4A GB2524831A (en) 2014-04-04 2014-04-04 New pharmaceutical use
GB1406115.4 2014-04-04
PCT/GB2015/050999 WO2015150793A1 (en) 2014-04-04 2015-03-31 New use of n,n-bis-2-mercaptoethyl isophthalamide

Publications (2)

Publication Number Publication Date
AU2015242374A1 AU2015242374A1 (en) 2016-10-13
AU2015242374B2 true AU2015242374B2 (en) 2019-10-10

Family

ID=50776843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015242374A Active AU2015242374B2 (en) 2014-04-04 2015-03-31 New use of N,N-bis-2-mercaptoethyl isophthalamide

Country Status (35)

Country Link
US (1) US9782368B2 (ru)
EP (1) EP3125876B8 (ru)
JP (1) JP6474423B2 (ru)
KR (1) KR102482699B1 (ru)
CN (1) CN106132405B (ru)
AU (1) AU2015242374B2 (ru)
BR (1) BR112016022880B1 (ru)
CA (1) CA2944113C (ru)
CL (1) CL2016002499A1 (ru)
CY (1) CY1121235T1 (ru)
DK (1) DK3125876T3 (ru)
EA (1) EA032116B1 (ru)
EC (1) ECSP16078100A (ru)
ES (1) ES2659174T3 (ru)
GB (1) GB2524831A (ru)
HR (1) HRP20180325T1 (ru)
HU (1) HUE036206T2 (ru)
IL (1) IL248027B (ru)
LT (1) LT3125876T (ru)
MA (1) MA39833B1 (ru)
ME (1) ME03012B (ru)
MX (1) MX2016012591A (ru)
NO (1) NO3125876T3 (ru)
NZ (1) NZ724678A (ru)
PE (1) PE20170586A1 (ru)
PH (1) PH12016501975A1 (ru)
PL (1) PL3125876T3 (ru)
PT (1) PT3125876T (ru)
RS (1) RS56905B1 (ru)
SA (1) SA516371966B1 (ru)
SG (1) SG11201607478RA (ru)
SI (1) SI3125876T1 (ru)
UA (1) UA119558C2 (ru)
WO (1) WO2015150793A1 (ru)
ZA (1) ZA201606406B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7201989B2 (ja) 2018-10-22 2023-01-11 株式会社松井製作所 粉粒体材料の貯留装置
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100227812A1 (en) * 2008-12-06 2010-09-09 Haley Boyd E Method of supplementing the diet and ameliorating oxidative stress

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
JP2011026204A (ja) * 2007-11-26 2011-02-10 Rei Furukawa タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物
US8575218B2 (en) 2009-09-28 2013-11-05 The University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from tissues and formulations therefor
IN2012DN02586A (ru) 2009-09-28 2015-08-28 Univ Kentucky Res Found
US20110237776A1 (en) 2010-03-25 2011-09-29 Haley Boyd E Aromatic compounds with sulfur containing ligands
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100227812A1 (en) * 2008-12-06 2010-09-09 Haley Boyd E Method of supplementing the diet and ameliorating oxidative stress

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATEL, R. B. et al. Toxicology Mechanisms and Methods (2012) vol. 22, no. 5, pages 383-396 *

Also Published As

Publication number Publication date
BR112016022880B1 (pt) 2022-09-13
CA2944113A1 (en) 2015-10-08
CA2944113C (en) 2022-06-21
SI3125876T1 (en) 2018-04-30
SA516371966B1 (ar) 2019-04-14
EA032116B1 (ru) 2019-04-30
NO3125876T3 (ru) 2018-04-28
ME03012B (me) 2018-10-20
CN106132405A (zh) 2016-11-16
CY1121235T1 (el) 2020-05-29
EP3125876B1 (en) 2017-11-29
RS56905B1 (sr) 2018-05-31
SG11201607478RA (en) 2016-10-28
ZA201606406B (en) 2018-04-25
PT3125876T (pt) 2018-02-22
AU2015242374A1 (en) 2016-10-13
MX2016012591A (es) 2017-04-06
LT3125876T (lt) 2018-02-12
US9782368B2 (en) 2017-10-10
BR112016022880A2 (ru) 2017-08-15
EP3125876A1 (en) 2017-02-08
MA39833A (fr) 2017-02-08
WO2015150793A1 (en) 2015-10-08
DK3125876T3 (en) 2018-01-15
IL248027B (en) 2019-03-31
HUE036206T2 (hu) 2018-06-28
PE20170586A1 (es) 2017-05-20
CL2016002499A1 (es) 2017-01-27
PL3125876T3 (pl) 2018-05-30
EP3125876B8 (en) 2018-01-24
GB201406115D0 (en) 2014-05-21
ES2659174T3 (es) 2018-03-14
PH12016501975A1 (en) 2017-01-09
KR20160140929A (ko) 2016-12-07
US20170157072A1 (en) 2017-06-08
HRP20180325T1 (hr) 2018-04-06
UA119558C2 (uk) 2019-07-10
GB2524831A (en) 2015-10-07
EA201692013A1 (ru) 2017-03-31
JP6474423B2 (ja) 2019-02-27
NZ724678A (en) 2022-12-23
KR102482699B1 (ko) 2022-12-28
CN106132405B (zh) 2019-06-18
MA39833B1 (fr) 2018-04-30
ECSP16078100A (es) 2018-03-31
JP2017511307A (ja) 2017-04-20

Similar Documents

Publication Publication Date Title
RU2685706C2 (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
WO2021207325A1 (en) Natural extract and their components for use in mitigating acute respiratory distress syndrome
KR20210043601A (ko) 점액 과분비를 치료하기 위한 점액 용해제를 함유한 조성물 및 이의 투약 기구
AU2015242374B2 (en) New use of N,N-bis-2-mercaptoethyl isophthalamide
JP2015083596A (ja) チアゾール誘導体を使用する方法
JPS59219233A (ja) 気管支粘膜の炎症性異変の処置に適する医薬組成物
WO2016041439A1 (zh) 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂
US20180338936A1 (en) Methods and Compositions for the Treatment and Prevention of Allergic Rhinitis
Owen et al. A phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of inhaled GDC-0214, a JAK1 inhibitor, as single-and multiple-ascending doses in healthy volunteers
US9675569B2 (en) Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
Arnaudova Danevska et al. EFFECT OF NASAL CORTICOSTEROIDS ON OXIDATIVE STRESS PARAMETERS IN CHILDREN WITH ALLERGIC RHINITS
JP2009263384A (ja) Ｉ型アレルギー性疾患のアトピー性皮膚炎の症状を抑制するための内服薬
Bahramsoltani et al. Turmeric and Inflammatory Diseases: An Overview of Clinical Evidence
JP2005343846A (ja) アレルギー性鼻炎予防用医薬組成物
Lewis Perspective on Using Glutathione for a Wide Range of Patients with Chronic Inflammatory Response Syndromes.
JP2009263385A (ja) Ｉ型アレルギー性疾患の鼻炎の症状を抑制するための内服薬
CN108295090A (zh) 一种添加抗氧化维生素和矿物质的肠内营养制剂及应用
Leigh Inhaled corticosteroids in asthma
JP2009263387A (ja) Ｉ型アレルギー性疾患の喘息の症状を抑制するための内服薬
JP2016535793A (ja) 口腔アレルギー症候群の予防および治療のための製剤および方法
JP2009263386A (ja) Ｉ型アレルギー性疾患の花粉症の症状を抑制するための内服薬

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)